Post job

Hyperion Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Chris Rivera is the Hyperion Therapeutics's CEO. Hyperion Therapeutics has 750 employees, of which 12 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Hyperion Therapeutics executive team is 0% female and 100% male.
  • 48% of the management team is White.
  • 15% of Hyperion Therapeutics management is Hispanic or Latino.
  • 8% of the management team is Black or African American.
Work at Hyperion Therapeutics?
Share your experience

Rate Hyperion Therapeutics' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Chris Rivera

CEO

Chris Rivera's LinkedIn

Mark Blumling

Founder

Daniel G. Welch

Board Member

Jake Nunn

Board Member

Bo Jesper Hansen

Board Member

David W. Gryska

Board Member

James Healy

Board Member

Mr. Donald J. Santel

Chief Executive Officer

Mr. Donald J. Santel is a Chief Executive Officer at HYPERION THERAPEUTICS INC and is based in United States.

Rob Hopfner

Board Member

Thong le

Board Member

Do you work at Hyperion Therapeutics?

Does leadership effectively guide Hyperion Therapeutics toward its goals?

Hyperion Therapeutics jobs

Hyperion Therapeutics founders

Name & TitleBio
Mark Blumling

Founder

Hyperion Therapeutics board members

Name & TitleBio
Daniel G. Welch

Board Member

Jake Nunn

Board Member

Bo Jesper Hansen

Board Member

David W. Gryska

Board Member

James Healy

Board Member

Rob Hopfner

Board Member

Thong le

Board Member

Bijan Salehizadeh

Board Member

Hyperion Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Hyperion Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Hyperion Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Hyperion Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Hyperion Therapeutics. The data presented on this page does not represent the view of Hyperion Therapeutics and its employees or that of Zippia.

Hyperion Therapeutics may also be known as or be related to HYPERION THERAPEUTICS INC, Hyperion Therapeutics and Hyperion Therapeutics, Inc.